felin
infecti
periton
viru
fip
viru
fipv
felin
coronaviru
fcov
famili
coronavirida
caus
fatal
diseas
call
fip
wild
domest
cat
speci
cat
develop
fip
affect
sever
organ
includ
liver
lung
spleen
central
nervou
system
form
lesion
accompani
necrosi
pyogen
granulomat
inflamm
pedersen
cat
pleural
effus
ascit
fluid
accumul
fcov
mainli
compos
nucleocapsid
n
protein
envelop
e
protein
membran
protein
peplom
spike
protein
pedersen
fcov
classifi
serotyp
ii
accord
amino
acid
sequenc
protein
motokawa
et
al
motokawa
et
al
serotyp
consist
two
biotyp
fipv
felin
enter
coronaviru
fecv
fecv
infect
asymptomat
cat
contrast
fipv
infect
caus
fip
propos
fipv
aris
fecv
mutat
poland
et
al
vennema
et
al
exact
mutat
induc
factor
yet
clarifi
stoddart
scott
report
prolifer
periton
macrophag
associ
virul
correspond
author
tel
fax
email
address
hohdatsu
vmaskitasatouacjp
hohdatsu
fipv
fecv
exhibit
lower
prolifer
periton
macrophag
fipv
fipv
target
monocytesmacrophag
monocytesmacrophag
infect
enhanc
presenc
antibodi
antibodydepend
enhanc
ade
ade
activ
fipv
infect
induc
antifipv
antibodybound
virus
infect
monocytesmacrophag
bind
fc
portion
fc
receptor
cell
surfac
hohdatsu
et
al
corapi
et
al
olsen
et
al
protein
coronaviru
play
import
role
infect
target
cell
coronaviru
protein
divid
region
bosch
et
al
region
bind
cell
surfac
viru
receptor
region
involv
viralcel
fusion
presenc
neutral
antibodydepend
enhanc
epitop
region
fcov
also
report
corapi
et
al
kida
et
al
previous
prepar
neutral
monoclon
antibodi
mab
resist
mar
mutant
viru
use
virul
type
ii
laboratori
strain
fipv
kida
et
al
mar
mutant
virus
sever
amino
acid
neutral
epitop
region
mutat
compar
parent
strain
fipv
strain
fipv
mar
mutant
virus
type
ii
laboratori
strain
fecv
use
compar
differ
prolifer
monocytesmacrophag
virul
cat
furthermor
investig
whether
biolog
properti
mar
mutant
virus
relat
mutat
genom
feli
catu
whole
cell
grown
eagl
minimum
essenti
medium
contain
medium
fetal
calf
serum
fc
antibiot
felin
monocyt
alveolar
macrophag
cultur
rpmi
medium
contain
fc
antibiot
strain
fipv
strain
fecv
kida
et
al
briefli
mar
mutant
virus
prepar
use
monoclon
antibodi
mab
mab
mab
exampl
singl
mar
mutant
viru
prepar
use
mab
doubl
mar
mutant
virus
deriv
singl
mar
mutant
viru
mar
deriv
mar
mar
deriv
mar
felin
monocyt
isol
specif
pathogenfre
spf
cat
previous
describ
dewerchin
et
al
felin
alveolar
macrophag
obtain
bronchoalveolar
lavag
hank
balanc
salt
solut
hbss
antifcov
antibodyneg
spf
cat
previous
describ
hohdatsu
et
al
ade
activ
enhanc
titer
index
mab
measur
employ
method
viru
suspens
tcid
mab
mab
mab
solut
mix
equival
volum
ratio
react
c
h
ml
reaction
solut
use
inocul
felin
alveolar
macrophag
cell
cultur
well
multipl
control
medium
alon
ad
viru
adsorpt
c
h
cell
wash
hbss
ml
mainten
medium
cultur
supernat
collect
h
cultur
supernat
use
plaqu
assay
enhanc
titer
index
log
log
b
number
plaqu
reaction
mab
cultur
fluid
hybridoma
cell
line
b
number
plaqu
reaction
medium
neutral
activ
neutral
titer
index
mab
mab
mab
measur
refer
method
report
kida
et
al
neutral
titer
index
c
c
c
number
plaqu
reaction
medium
number
plaqu
reaction
mab
cultur
fluid
hybridoma
cell
line
confluent
cell
monolay
multipl
inocul
l
sampl
dilut
viru
adsorpt
c
cell
wash
hbss
ml
growth
medium
contain
carboxymethyl
cellulos
ad
well
cultur
incub
c
day
fix
buffer
formalin
stain
crystal
violet
confluent
cell
multipl
inocul
strain
fipv
strain
fecv
mar
mutant
virus
tcid
c
h
wash
cell
cultur
media
cultur
supernat
collect
everi
h
felin
alveolar
macrophag
cell
felin
monocyt
cell
multipl
inocul
strain
fipv
strain
fecv
mar
mutant
virus
tcid
c
h
wash
cell
cultur
media
cultur
supernat
collect
everi
h
strain
fipv
strain
fecv
mar
mutant
virus
tcid
ml
administ
oral
spf
cat
cat
check
daili
clinic
sign
measur
bodi
temperatur
weight
cat
euthan
reach
previous
determin
human
endpoint
day
challeng
set
human
endpoint
meet
two
follow
point
lack
appetit
day
extrem
anemia
due
dyspnea
prolong
capillari
refil
time
fever
c
higher
follow
bodi
temperatur
reduct
c
jaundic
visibl
mucosa
cat
show
neurolog
symptom
immedi
euthan
fip
diagnos
confirm
upon
postmortem
examin
reveal
periton
pleural
effus
pyogranuloma
major
organ
experi
perform
accord
guidelin
anim
experi
kitasato
univers
viru
genom
rna
extract
virusinfect
cell
use
high
pure
rna
isol
kit
roch
diagnost
switzerland
accord
instruct
manufactur
rna
dissolv
elut
buffer
use
viru
genom
rna
templat
cdna
synthes
use
readytogo
rtpcr
bead
ge
healthcar
life
scienc
usa
revers
transcript
perform
final
volum
contain
g
oligo
dt
primer
result
solut
incub
c
h
synthes
cdna
cdna
amplifi
pcr
primer
sequenc
target
region
shown
fig
tabl
pcr
perform
total
volum
l
one
microlit
sampl
cdna
mix
l
primestar
buffer
takara
japan
l
dntp
mixtur
takara
japan
contain
mm
dntp
l
primer
mix
l
primestar
hs
dna
polymeras
uml
takara
japan
l
distil
water
use
pcr
thermal
cycler
dice
takara
japan
dna
amplifi
c
min
follow
cycl
denatur
c
primer
anneal
c
synthesi
c
min
final
extens
c
min
pcr
product
l
electrophores
dna
marker
agaros
gel
singlet
band
excis
transfer
microtub
dna
purifi
use
qiaquick
gel
extract
kit
qiagen
gmbh
germani
purifi
dna
sent
sigma
aldrich
japan
sequenc
sequenc
viru
genom
determin
analyz
employ
genetyx
comput
program
softwar
develop
japan
data
analyz
use
oneway
anova
test
data
fig
analyz
employ
mannwhitney
test
pvalu
consid
indic
signific
differ
compar
group
ade
neutral
activ
mab
mab
mab
mar
mutant
virus
ade
neutral
activ
mab
mab
mab
mar
mutant
virus
analyz
fig
mab
exhibit
potent
neutral
ade
activ
parent
strain
fipv
analysi
mar
mutant
viru
reactiv
mab
neutral
ade
activ
mab
reduc
mar
mar
mar
reduct
neutral
ade
activ
mab
mar
mar
mab
mar
mar
mar
also
observ
interestingli
three
mab
exhibit
potent
neutral
activ
ade
activ
fecv
strain
replic
mar
mutant
viru
cell
felin
monocyt
alveolar
macrophag
investig
fig
signific
differ
note
viru
product
among
cell
inocul
strain
fipv
mar
mutant
virus
strain
fecv
contrast
viru
product
significantli
decreas
felin
monocyt
alveolar
macrophag
inocul
mar
mutant
viru
mar
mar
mar
fecv
compar
strain
fipv
particular
viral
product
mar
mar
fecv
markedli
decreas
felin
alveolar
macrophag
virul
mar
mutant
virus
investig
use
spf
cat
chang
bodi
weight
temperatur
mar
mutant
viru
inocul
measur
cat
bodi
weight
markedli
chang
tend
decreas
week
fip
develop
cat
develop
fip
fig
bodi
temperatur
rose
day
viru
inocul
cat
fig
bodi
temperatur
markedli
chang
cat
inocul
fipv
wherea
variat
small
cat
inocul
fecv
cat
inocul
mar
mar
mar
bodi
temperatur
chang
similar
fipv
cat
chang
cat
inocul
mar
mar
mar
similar
fecv
fig
show
surviv
rate
cat
inocul
strain
fipv
n
strain
fecv
n
mar
mutant
virus
n
surviv
rate
cat
inocul
strain
fipv
surviv
rate
cat
inocul
mar
mar
respect
show
signific
differ
compar
cat
inocul
strain
fipv
contrast
mar
mar
mar
mar
show
signific
decreas
p
virul
spf
cat
compar
strain
fipv
cat
euthan
day
viru
inocul
autopsi
cat
inocul
fipv
granulomat
lesion
present
omentum
intestin
three
cat
inocul
mar
pleural
effus
granulomat
lesion
observ
lung
lesion
observ
cat
nucleotid
sequenc
genom
mar
mutant
virus
determin
compar
strain
fipv
refer
report
kida
et
al
nucleotid
sequenc
orf
mar
mutant
virus
mar
mutant
viru
nucleotid
sequenc
region
gene
mutat
tabl
gene
mar
mar
mar
nucleotid
gene
delet
nonsens
mutat
found
virus
amino
acid
ntermin
protein
predict
amino
acid
sequenc
conserv
strain
fipv
fipv
mar
mutant
viru
indic
asterisk
inform
refer
articl
kida
et
al
b
amino
acid
present
neutral
epitop
site
fipv
corapi
et
al
kida
et
al
delet
tabl
mutat
found
orf
orf
orf
e
orf
orf
n
orf
mar
mutant
virus
mar
mutant
mhv
ross
river
viru
rabi
viru
venezuelan
equin
enceph
viru
becam
less
virul
parent
strain
coulon
et
al
johnson
et
al
vrati
et
al
wang
et
al
howev
virul
mar
mutant
viru
fipv
cat
remain
unexamin
cat
inocul
strain
fipv
frequent
develop
fip
specif
mar
mutant
viru
strain
fipv
use
inocul
cat
clearli
demonstr
chang
virul
furthermor
strain
fipv
suitabl
examin
correl
prolifer
fipv
monocytesmacrophag
virul
cat
high
prolifer
strain
fipv
monocytesmacrophag
corapi
et
al
hohdatsu
et
al
report
fipv
mab
exhibit
potent
ade
activ
macrophag
report
suggest
neutral
antibodydepend
enhanc
epitop
present
region
fipv
hypothesi
verifi
reveal
mab
lost
neutral
activ
mar
mutant
virus
also
lost
ade
activ
show
neutral
antibodydepend
enhanc
epitop
present
region
protein
fipv
hypothes
hand
mab
neutral
fecv
cell
exhibit
ade
activ
macrophag
reason
absenc
ade
activ
fecv
unclear
fecv
tabl
exhibit
higher
amino
acid
sequenc
homolog
structur
protein
e
n
orf
fipv
strain
homolog
nonstructur
protein
orf
less
moreov
nonstructur
proteinencod
orf
fecv
analyz
investig
differ
ade
activ
fecv
fipv
investig
differ
replic
mode
includ
cellular
invas
process
monocytesmacrophag
necessari
corapi
et
al
kida
et
al
investig
neutral
epitop
fipv
use
mar
mutant
virus
divid
neutral
epitop
region
protein
residu
residu
site
unclear
whether
site
involv
replic
abil
fipv
monocytesmacrophag
confirm
viral
replic
abil
monocytesmacrophag
reduc
virus
two
amino
acid
mutat
site
mar
mar
mar
suggest
site
fipv
import
viral
replic
monocytesmacrophag
mar
mar
mar
nucleotid
gene
delet
nucleotid
mutat
stop
codon
tga
propos
fipv
becom
less
virul
gene
delet
herrewegh
et
al
fipv
gene
easili
delet
viral
passag
cell
howev
delet
found
gene
mar
mar
spite
undergo
number
passag
mar
mar
reason
gene
delet
passag
fipv
unknown
studi
need
futur
mar
contain
two
nucleotid
delet
gene
replic
well
monocytesmacrophag
despit
virul
cat
lost
show
reduc
virul
fipv
gene
mutat
relat
replic
abil
monocytesmacrophag
function
protein
encod
gene
protein
fipvinfect
cat
unclear
nonstructur
protein
fcov
similar
protein
protein
suggest
involv
viral
transfer
intestin
epitheli
cell
macrophag
chang
et
al
essenti
function
protein
analyz
necessari
prepar
recombin
protein
investig
function
everi
round
replic
multipl
mutat
might
expect
due
infidel
rnadepend
rna
polymeras
coronavirus
woo
et
al
fcov
multipl
mutat
induc
sever
passag
observ
fipv
strain
black
fipv
black
type
fcov
teke
et
al
howev
mutat
found
genom
despit
fact
mar
mutant
virus
gener
fipv
type
ii
fcov
sever
passag
independ
differ
cultur
presenc
neutral
monoclon
antibodi
although
reason
contradict
unclear
differ
fidel
rnadepend
rna
polymeras
type
ii
fcov
may
involv
vignuzzi
et
al
suggest
genom
divers
decreas
virus
highfidel
rnadepend
rna
polymeras
actual
mani
gene
mutat
observ
among
type
fcov
strain
mutat
detect
type
ii
fcov
investig
necessari
concern
relationship
fcov
polymeras
fidel
genom
mutat
prolifer
mar
mutant
virus
monocytesmacrophag
tend
correl
virul
cat
howev
mar
becom
less
virul
cat
although
prolifer
well
monocytesmacrophag
vitro
result
inconsist
theori
prolifer
fcov
monocytesmacrophag
correl
virul
pedersen
report
oral
inocul
use
strain
fipv
caus
fip
cat
intraperiton
inocul
contrast
oral
inocul
use
strain
fipv
caus
fip
cat
intraperiton
inocul
thu
mar
may
also
becom
virul
via
inocul
rout
futur
associ
among
prolifer
monocytesmacrophag
onset
fip
development
mechan
via
parenter
transmiss
rout
examin
use
strain
mar
mar
mutant
virus
addit
necessari
prepar
mab
mutant
viru
without
mutat
region
neutral
epitop
perform
similar
experi
propos
fipv
aris
fecv
mutat
poland
et
al
vennema
et
al
howev
recent
brown
et
al
theoret
demonstr
fip
develop
via
horizont
infect
fipv
basi
theori
fipv
fecv
preval
among
cat
mention
fipv
may
caus
clinic
symptom
via
transmiss
rout
indic
result
virul
fipv
alter
base
amino
acid
chang
result
fcov
includ
fipv
regard
group
variou
virul
virus
futur
chang
virul
caus
gene
mutat
manifest
virul
due
transmiss
rout
examin
fcov
comprehens
elucid
virul
fipv
involv
fipv
replic
monocytesmacrophag
aggrav
fip
suggest
agent
inhibit
fipv
infect
monocytesmacrophag
develop
may
use
treat
fip
exampl
neutral
epitopebind
peptidomimet
may
inhibit
fipv
infect
monocytesmacrophag
without
exhibit
ade
activ
howev
neutral
antibodydepend
enhanc
epitop
type
fipv
account
field
fipv
identifi
unlik
type
ii
fipv
prepar
therapeut
drug
target
neutral
epitop
identif
neutral
epitop
type
fipv
necessari
recent
method
prepar
type
fcov
employ
revers
genet
system
also
establish
teke
et
al
futur
desir
examin
neutralizingantibodydepend
enhanc
epitop
type
fcov
vitro
vivo
result
indic
virul
fipv
base
amino
acid
chang
inde
amino
acid
chang
demonstr
mar
mutant
virus
virus
reduc
virul
also
delet
gene
orf
gene
delet
probabl
readili
acquir
passag
fcov
vitro
suggest
correl
loss
virul
herrewegh
et
al
specul
import
virul
mutat
actual
relat
delet
gene
studi
suggest
mutat
neutral
epitop
type
ii
fipv
delet
orf
gene
relat
loss
virul
also
cat
descri
fcovinfect
cat
develop
fip
type
ii
fipv
field
mostli
type
fipv
hohdatsu
et
al
kummrow
et
al
pedersen
necessari
perform
similar
studi
concern
type
fipv
